Profilaxis de la hepatitis B después de trasplante hepático y tratamiento de la recidiva

Samuel, 1993, Liver transplantation in European patients with the hepatitis B surface antigen, N Engl J Med, 329, 1842, 10.1056/NEJM199312163292503 Steinmuller, 2002, Increasing applicability of liver transplantation for patients with hepatitis B-related liver disease, Hepatology, 35, 1528, 10.1053/jhep.2002.33681 Terrault, 2005, Management of the hepatitis B virus in the liver transplantation setting: a European and an American perspective, Liver Transpl, 11, 716, 10.1002/lt.20492 Schiff, 2003, Adefovir dipivoxil therapy for lamivudine-resistant hepatitis B in pre– and post-liver transplantation patients, Hepatology, 38, 1419 Shouval, 2000, Hepatitis B immune globulin to prevent hepatitis B virus graft reinfection following liver transplantation: a concise review, Hepatology, 32, 1189, 10.1053/jhep.2000.19789 Lauchart, 1987, Long-term immunoprophylaxis of hepatitis B virus reinfection in recipients of human liver allografts, Transplant Proc, 19, 4051 Roche, 2003, Liver transplantation for hepatitis B virusrelated liver disease: indications, prevention of recurrence and results, J Hepatol, 39, S181, 10.1016/S0168-8278(03)00335-0 McGory, 1996, Improved outcome of orthotopic liver transplantation for chronic hepatitis B cirrhosis with aggressive passive immunization, Transplantation, 61, 1358, 10.1097/00007890-199605150-00013 Grellier, 1996, Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis, Lancet, 348, 1212, 10.1016/S0140-6736(96)04444-3 Neff, 2004, Outcomes in liver transplant recipients with hepatitis B virus: resistance and recurrence patterns from a large transplant center over the last decade, Liver Transpl, 10, 1372, 10.1002/lt.20277 Roche, 2003, HBV DNA persistence 10 years after liver transplantation despite successful anti-HBS passive immunoprophylaxis, Hepatology, 38, 86, 10.1053/jhep.2003.50294 Naoumov, 2001, Randomized trial of lamivudine versus hepatitis B immunoglobulin for long-term prophylaxis of hepatitis B recurrence after liver transplantation, J Hepatol, 34, 888, 10.1016/S0168-8278(01)00039-3 Buti, 2003, A randomized study comparing lamivudine monotherapy after a short course of hepatitis B immune globulin (HBIg) and lamivudine with long-term lamivudine plus HBIg in the prevention of hepatitis B virus recurrence after liver transplantation, J Hepatol, 38, 811, 10.1016/S0168-8278(03)00087-4 Perrillo, 1999, Multicenter study of lamivudine therapy for hepatitis B after liver transplantation. Lamivudine Transplant Group, Hepatology, 29, 1581, 10.1002/hep.510290507 Bárcena, 2005, Study on the efficacy and safety of adefovir dipivoxil treatment in post-liver transplant patients with hepatitis B virus infection and lamivudine-resistant hepatitis B virus, Transplant Proc, 37, 3960, 10.1016/j.transproceed.2005.10.061 Neff, 2004, Tenofovir therapy for lamivudine resistance following liver transplantation, Ann Pharmacother, 38, 1999, 10.1345/aph.1E280 Chang, 2006, A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B, N Engl J Med, 354, 1001, 10.1056/NEJMoa051285